Raleigh, North Carolina — According to state and local development sources, Merz Therapeutics plans to build out 29,821 square feet of new space in Raleigh. The company plans to occupy the new space at 6601 Six Forks Rd Ste 400 in Raleigh, on or about July 1, 2024. According to the company website At Merz Therapeutics, we seek to address the unique needs of people who suffer from movement disorders, neurological conditions, and other health conditions that severely impact patients quality of life. With our patient-centric approach, cutting-edge research and development efforts, highly-scientific medical affairs resources and dedicated commercial teams, we continue the advancement of new and individualized treatment standards, including botulinum toxin. Merz Therapeutics is headquartered in Frankfurt am Main, Germany and is represented in more than 90 countries, with a North America affiliate based in Raleigh, North Carolina. Merz Therapeutics GmbH is part of the Merz Group, a privately held, family-owned company that has dedicated more than 110 years to developing innovations that serve unmet patient and customer needs.

To learn more about Merz Therapeutics, visit http://www.merztherapeutics.com/

Company Contact:
Stefan Konig, Chief Executive Officer
stefan@merztherapeutics.com
https://www.linkedin.com/in/stefan-k%C3%B6nig-9920b61b/
919-582-8000

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.